Navigation Links
Obesity journal publishes new study on lorcaserin, a weight-loss medication recommended for approval by FDA advisory panel
Date:6/26/2012

SILVER SPRING, Md., June 26, 2012 /PRNewswire-USNewswire/ -- A new study on the effects of lorcaserin, a drug recently recommended for approval by an FDA advisory panel for the treatment of obesity, was just published in the scientific journal Obesity.  The journal is published by The Obesity Society (TOS), the leading scientific organization in North America dedicated to the study of obesity.  Authors include several TOS members including Patrick O'Neil, PhD, President, and Steven Smith, MD, Vice-President of TOS.

(Logo: http://photos.prnewswire.com/prnh/20120531/DC16753LOGO )

The study, titled BLOOM-DM (Behavioral Modification and Lorcaserin for Obesity and Overweight Management in Diabetes Mellitus) evaluated 604 obese and overweight participants with type 2 diabetes in a double-blind placebo-controlled randomized trial over a one-year treatment period. Although all participants received systematic lifestyle change counseling, those on the medication lost 4.5 – 5.0% of their initial bodyweight compared to a loss of 1.5% by patients on the inactive placebo. According to lead author O'Neil, "That's a very meaningful difference in weight loss for this population. Importantly, the patients on active medication also showed much greater improvement on a key measure of blood glucose control."

Lorcaserin is a selective serotonin receptor agonist that works specifically on appetite signals in the brain. It has been developed by Arena Pharmaceuticals, which sponsored the trial. In previous clinical trials, lorcaserin decreased body weight in non-diabetic overweight and obese individuals. Although current American Diabetes Association treatment guidelines recommend that individuals with type 2 diabetes achieve modest weight loss (5–7%) to improve glycemic control, weight loss has historically been more difficult to achieve among patients with type 2
'/>"/>

SOURCE The Obesity Society
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. MedVantx MedStart™ Solves Problem Highlighted in Study Published in Journal of the American Board of Family Medicine - Expired Medications in Physician Office Sample Closets
2. Call for Entries: International Bureau for Epilepsy and UCB launch the 2012 Excellence in Epilepsy Journalism Award to recognize exceptional reporting on epilepsy
3. Elsevier and the Society for Vascular Surgery Announce Forthcoming Launch of Journal of Vascular Surgery: Venous and Lymphatic Disorders
4. NAMS Journal Menopause Reflects on the WHI 10 Years Later
5. Cardiac Dimensions® Announces Publication of TITAN Clinical Trial Data in European Journal of Heart Failure
6. Study Results of Novocures NovoTTF™ Pivotal Phase 3 Trial Published in European Journal of Cancer
7. Telik Announces the Publication of Two Reports in the Journal Of Hematology & Oncology Describing the Results of a Clinical Study of Telintra® in Combination With Revlimid® and a Genomic Study Designed to Identify Genes That Predict Response to Teli
8. Elsevier Selected as New Publisher of The American Journal of Geriatric Psychiatry
9. HemoShear Publishes Key Review on Human-Relevant Organotypic Systems
10. OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
11. Study Confirms Daniels Sharpsmart Helps Hospitals Reduce Carbon Footprint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... , July 20, 2015 Research ... addition of the "Key Pharma News Issue" ... This acquisition bolsters Gilead Sciences, burgeoning oncology pipeline ... will make further oncology deals in 2015, with ... of 2016. Key Pharma News ...
(Date:7/27/2015)... Belgium , July 27, 2015 /PRNewswire/ ... life sciences company focused on developing blood-based diagnostic tests ... conditions, today announced that it has engaged the services ... Specimen Solutions, Inc. (GSS), to support initial U.S. market ... Under the agreement, GSS will target ...
(Date:7/27/2015)... , July 27, 2015 Syneron ... ) , a global market leader in the aesthetic ... Korean Ministry of Food and Drug Safety (MFDS) regulatory ... clearance, the Company can fulfill PicoWay orders from its ... Korea anticipated later in the third quarter 2015. ...
Breaking Medicine Technology:Key Pharma News Issue - Gilead will make further oncology deals in 2015 2Key Pharma News Issue - Gilead will make further oncology deals in 2015 3VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 2VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 3VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 4VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 5VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 6VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 7Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 2Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 3Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 4
... Interventional Radiology Treatment Relieves Pain From Herniated Disks; ... but With Fewer Complications, Shorter Recovery TimeSAN DIEGO, ... treatment--that safely and effectively uses oxygen/ozone to relieve ... the United States in the next few years, ...
... Minimally Invasive "Lumpectomy" -- as Effective as Surgery -- ... Mapping Biopsy Changed Patients, Management 70 Percent of the ... -- a minimally invasive interventional radiology treatment for prostate ... diseased tumors and can be considered a first-line treatment ...
Cached Medicine Technology:Oh, My Aching Back: Give Me a Shot of Ozone 2Oh, My Aching Back: Give Me a Shot of Ozone 3Oh, My Aching Back: Give Me a Shot of Ozone 4Oh, My Aching Back: Give Me a Shot of Ozone 5Freezing Prostate Cancer Does a Man's Body Good 2Freezing Prostate Cancer Does a Man's Body Good 3Freezing Prostate Cancer Does a Man's Body Good 4Freezing Prostate Cancer Does a Man's Body Good 5Freezing Prostate Cancer Does a Man's Body Good 6Freezing Prostate Cancer Does a Man's Body Good 7
(Date:7/27/2015)... ... July 28, 2015 , ... Conducting Advanced Root ... to Improve the Quality of Investigations , **Presented by FDAnews and Learning Plus**, ... CAPAs have been the #1 reason for 483 observations since 1997! , The ...
(Date:7/27/2015)... NY (PRWEB) , ... July 28, 2015 , ... ... a 2015-2016 inductee into the NAPW VIP Woman of the Year Circle. She is ... and over 200 operating Local Chapters, NAPW is the nation’s leading networking organization exclusively ...
(Date:7/27/2015)... ... July 27, 2015 , ... ... science of the little-known and incurable disease, facioscapulohumeral muscular dystrophy (FSHD), today announced ... of Neurology (AAN). The FSHD care guideline is published today. , This ...
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... North Central ... 2015. , The center invites all those prospective joint-replacement patients, along with their ... Thursday of each month, with Monday classes (Aug 6, Sept 8 [Tue due to ...
(Date:7/27/2015)... ... July 27, 2015 , ... ... is a professional and in-depth research report. The report provides basic information ... market analysis etc. This report covers the global (US, Europe, Japan etc) ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 2Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 3Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 4Health News:NAPW Inducts Jane Simmons, Counseling Intern at Omar Bradley Middle School of the Northeast Independent School District , Into its VIP Woman of the Year Circle 2Health News:First-Ever FSHD Evidence-based Care Guideline Published by the American Academy of Neurology 2Health News:North Central Surgical Center Hospital to Hold Joint Wellness Classes 2Health News:Calcium Propionate Market Global Suppliers and Manufacture Analysis 2Health News:Calcium Propionate Market Global Suppliers and Manufacture Analysis 3
... Address FDA,s Next Big Challenge, Is the Food ... Devices to Physicians and the Public?, WASHINGTON, Nov. ... device that repairs damaged cells and treats cancer through,electromagnetic ... its apparent connection to patient injuries and death. However,on ...
... - The Westaim Corporation,announced today that it has reached ... in Canadian third party asset-backed commercial paper (ABCP) with,a ... $6.0 million.,Westaim retains the right to receive additional proceeds ... six months; in such event, Westaim,will receive 50 per ...
... (Nasdaq: FLEX ),today announced that it will report ... earnings conference call, hosted by Flextronics,s senior,management, will be ... results,of the Company for its third quarter ended December ... via the Internet and may be,accessed by logging on ...
... may be undertreated compared to white patients, research suggests , ... likely than white women to suffer severe pain linked to ... than 1,100 patients in 19 countries. , The women -- ... given a pain test called the Brief Pain Inventory repeatedly ...
... Kocot and Robert,Seidman Headline Agenda at FDA/CMS Summit ... has,progressed beyond a topic of industry insider buzz ... and private payers. Value isn,t a new,concept in ... for buying and,selling biopharmaceuticals? How is value calculated, ...
... Nov. 26 Pharmasset, Inc.,(Nasdaq: VRUS ) ... & Sales, responsible for coordinating the global product ... Higgins, who,has served as a consultant to Pharmasset ... Virology at Hoffmann-LaRoche, Inc. His areas,of expertise include ...
Cached Medicine News:Health News:Food and Drug Law Institute Sponsors Colloquium on Communicating Risk/Safety Drug Information 2Health News:Westaim reduces ABCP exposure 2Health News:Flextronics to Report Third Quarter Results 2Health News:Defining the Value of Medicine in an Evidence-Based Healthcare Marketplace 2Health News:Defining the Value of Medicine in an Evidence-Based Healthcare Marketplace 3Health News:Pharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & Sales 2Health News:Pharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & Sales 3
Inquire...
Glucose tubes contain an anti-coagulant and a stabiliser. The tubes are ideal for glucose and lactate determinations....
BD Vacutainer® Fluoride Tubes - Glass...
VACUETTE Trace Element tubes - Ridged (safety screw cap) are designed to test trace elements such as Cu, Zn, Pb, etc....
Medicine Products: